# Study of CM313 in Healthy Subjects

> **NCT06285227** · PHASE1 · UNKNOWN · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 51 (estimated)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** CM313 injection

## Key facts

- **NCT ID:** NCT06285227
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-12
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06285227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06285227, "Study of CM313 in Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06285227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*